Services

    • Ketamine Assisted Psychotherapy

    • Integration Psychotherapy

    • Psychedelic Psychotherapy

    • EMDR

    • Somatic

    • Individual Therapy

    • Coaching

    • Couples Treatment

    • Individuals

    • Couples

    • Adolescents (with Family involvement)

    • Families

  • Ketamine has been shown to be successful in treating the following:

    • Post Traumatic Stress Disorder

    • Depression

    • Suicidal Thoughts/ Ideations

    • Bipolar Disorder

    • Anxiety Disorder

    • Hormonal Mood Disorder (PMSD, Post Partum Depression)

    • Eating Disorders as part of mood disorder; in conjunction with eating disorder team

    • Obsessive Compulsive Disorder

    • Life threatening illness

    • In-Depth Psychiatric/Medical Assessment, Initial Evaluation, and Screening Intake – $450

    • In-Office Sub-Lingual lozenge and/or Intramuscular (IM) Sessions – $1025 per session.

    • Follow-up Hour-Long Integration Sessions with No Ketamine Medicine (part of the continuous KAP Integration Process) –fee schedule sent upon request.

    Integration:

    Individuals $275/hour

    Couples $350-400/hour

  • A Sequenced Approach to Psychedelic-Assisted Psychotherapy

    An educational overview of a phased clinical framework

    Overview

    Psychedelic-assisted psychotherapy is not one intervention but a family of related tools, each with a distinct therapeutic action. In this practice, treatment is organized as a sequenced framework rather than a single medicine used in isolation — moving deliberately through stages, each building the ground the next stage needs. This approach draws on the clinical and theoretical synthesis developed by Travis Trotter, Psy.D. (Trotter, 2025), which frames the arc of psychedelic-assisted treatment through the lens of depth psychology and the process of individuation — the lifelong work of becoming more fully oneself.

    Not every client moves through every phase, and not every phase is right for every presentation. The sequencing below represents an idealized structure — the shape treatment can take when a client's needs, readiness, and clinical picture call for the fuller arc. Any actual course of treatment is individualized in collaboration with the client, informed by ongoing clinical assessment at each transition point.

    The Three-Phase Framework

    Phase One — Stabilization

    Ketamine

    Ketamine is typically the entry point into this work. Its action is dissociative and, at sufficient dose, ego-dissolving — offering a direct, embodied experience of loosening one's habitual sense of self and psychological structure. For many clients, especially those whose difficulties are organized around rigidity, control, or an overly fixed sense of identity, this dissolution is not incidental — it is the therapeutic mechanism itself. Letting go of inherent structure, safely and with support, and discovering that one remains intact and safe on the other side, can begin to loosen patterns that talk therapy alone has not been able to shift.

    Ketamine also carries a well-established mood-regulating action distinct from the ego-dissolving effect described above. For clients presenting with depression and anxiety — whether as a primary mood disorder or as symptoms stemming from PTSD — ketamine can meaningfully decrease symptom severity and help regulate mood in a way that is often more rapid than conventional pharmacology. This stabilizing effect matters clinically beyond the ketamine phase itself: a client who is less burdened by acute depressive or anxious symptoms has more internal freedom and resilience to engage the deeper relational and existential work of the phases that follow.

    Treatment typically begins with at least one preparatory session — more as needed, number to be determined based on the individual — to establish the therapeutic relationship in this modality, orient the client to the process, and address logistics. From there, ongoing preparation is built directly into each medicine session — approximately an hour of grounding conversation precedes dosing. An initial low-dose session allows the clinician to observe how the client responds before moving toward the fuller dissolving range where the deeper work becomes accessible. Each medicine session is followed by dedicated integration work, translating what emerges in the altered state into lasting change in daily life and thought.

    In the language of the Hero's Journey, this phase corresponds to the Call and the Threshold — the initial willingness to leave familiar ground and step into the unknown, supported by the safety of preparation.

    Phase Two — Engagement

    MDMA

    Where indicated, treatment may move next to MDMA-assisted psychotherapy. MDMA's primary action is one of emotional safety and relational repair — it lowers defensive reactivity and fear response while preserving clarity of thought, creating conditions in which attachment wounds, relational trust, and emotionally difficult material can be approached directly rather than avoided. This phase is often where the relational and attachment-based roots of a client's presentation become most directly workable.

    As with ketamine work, each medicine session is bracketed by preparation and followed by dedicated integration, allowing the emotional material accessed during the session to be metabolized and carried forward.

    This phase corresponds to the Abyss and the Ordeal — the deepest point of the journey, where the traveler confronts what has been most difficult to face, made survivable by the relational safety this medicine supports.

    Phase Three — Synthesis

    Psilocybin

    The final phase, where indicated, uses psilocybin to support existential insight and identity reconstruction. Having built stability (Phase One) and relational safety (Phase Two), the client is often better positioned to engage psilocybin's characteristic depth — questions of meaning, self, mortality, and one's place in a larger pattern — without that depth becoming disorganizing. This phase frequently draws on archetypal and symbolic material, and integration here often focuses on weaving the insight gained into a coherent, forward-facing sense of identity.

    This phase corresponds to the Road Back and the Return — carrying what was found in the depths back into ordinary life, and integrating it into a self that can continue forward changed.

    On sequencing and individualization

    This three-phase arc — stabilization, engagement, synthesis — is offered as an educational model of ideal sequencing, not a fixed prescription. Which medicines are used, in what order, and over what timeline is a clinical determination made collaboratively with each client, based on their history, readiness, and how they respond at each stage. Some clients benefit from only one phase; others move through the full arc over an extended course of treatment.

    A note on scope: This overview is educational and describes a general clinical framework used in this practice. It does not constitute medical advice, a treatment recommendation for any individual, or a guarantee of any particular outcome or sequence of care. Psychedelic-assisted psychotherapy is provided within applicable legal and regulatory frameworks, under appropriate medical supervision, and following individualized clinical assessment. Naturalistic clinical work of this kind is distinct from formal clinical trial research; any prior clinical trial experience referenced in this practice's background (including MAPS-affiliated MDMA trial work) was conducted under separate, formally regulated trial protocols and is not equivalent to the naturalistic treatment described here.